https://www.selleckchem.com/EGFR(HER).html
To investigate the causes of missed diagnosis in mpMRI/TRUS fusion-guided targeted prostate biopsy. The clinical data of 759 patients who underwent transperineal prostate biopsy from March 2021 to June 2021 at Nanjing DrumTower Hospital were retrospectively analyzed. Twenty-one patients had MRI contraindications. Ultimately, 738 patients completed mpMRI/TRUS fusion-guided targeted prostate biopsy + 12-core transperineal systematic biopsy after mpMRI and PI-RADS scoring. The pathological diagnoses from targeted and systematic biopsy were compar
Like
Comment
Share
